Mutation scanning by meltMADGE: Validations usingBRCA1andLDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population
- 5 July 2005
- journal article
- research article
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 15 (7) , 967-977
- https://doi.org/10.1101/gr.3313405
Abstract
We have developed a mutation-scanning approach suitable for whole population screening for unknown mutations. The method, meltMADGE, combines thermal ramp electrophoresis with MADGE to achieve suitable cost efficiency and throughput. The sensitivity was tested in blind trials using 54 amplicons representing the BRCA1 coding region and a panel of 94 unrelated family breast cancer risk consultands previously screened in a clinical diagnostic laboratory. All 10 common polymorphisms, 15/15 previously identified disease-causing mutations, and three previously untested single base changes were identified. Assays of LDLR exons 3 and 8 were validated in 460 familial hypercholesteremics and detected 8/9 known variants. We then applied the exon 3 assay in several DNA banks representing ∼8000 subjects with known cholesterol values and applied both assays in one DNA bank (n = 3600). In exon 3 we identified one previously reported moderate mutation, P84S (n = 1), also associated with moderate hypercholesteremia in this subject; an unreported silent variant, N76N (n = 1); and known severe hypercholesteremia splice mutation 313+1G→A (n = 2). Around exon 8 we identified a paucimorphism (n = 35) at the splice site 1061–8T→C (known to be in complete linkage disequilibrium with T705I) and unreported sequence variants 1186+11G→A (n = 1) and D335N G→A (n = 1). The cholesterol value for D335N was on the 96.2 percentile and for T705I, 2/35 carriers were above the 99th percentile. Thus, variants with predicted severe, moderate, and no effect were identified at the population level. In contrast with case collections, CpG mutations predominated. MeltMADGE will enable definition of the full population spectrum of rare, paucimorphic, severe, moderate (forme fruste), and silent mutations and effects.Keywords
This publication has 41 references indexed in Scilit:
- A novel point mutation (Pro84 ← Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemiaClinical Genetics, 2008
- Evidence of Admixture from Haplotyping in an Epidemiological Study of UK Caucasian Males: Implications for Association AnalysesHuman Heredity, 2004
- Clustering of risk factors and social class in childhood and adulthood in British women's heart and health study: cross sectional analysisBMJ, 2004
- Independent effects of the −219 G>T and ε2/ε3/ε4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis StudyEuropean Journal of Human Genetics, 2003
- IMPACT OF GENE PATENTS ON THE COST-EFFECTIVE DELIVERY OF CARE: THE CASE OF BRCA1 GENETIC TESTINGInternational Journal of Technology Assessment in Health Care, 2003
- I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levelsJournal of Medical Genetics, 2000
- Sequence specificity in CpG mutation hotspotsFEBS Letters, 1996
- Utilities for high throughput use of the single strand conformational polymorphism method: screening of 791 patients with familial hypercholesterolaemia for mutations in exon 3 of the low density lipoprotein receptor gene.Journal of Medical Genetics, 1995
- Characterization of a Splice-Site Mutation in the Gene for the LDL Receptor Associated With an Unpredictably Severe Clinical Phenotype in English Patients With Heterozygous FHArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjectsAtherosclerosis, 1994